Notch and TLR signaling coordinate monocyte cell fate and inflammation

  1. Jaba Gamrekelashvili  Is a corresponding author
  2. Tamar Kapanadze
  3. Stefan Sablotny
  4. Corina Ratiu
  5. Khaled Dastagir
  6. Matthias Lochner
  7. Susanne Karbach
  8. Philip Wenzel
  9. Andre Sitnow
  10. Susanne Fleig
  11. Tim Sparwasser
  12. Ulrich Kalinke
  13. Bernhard Holzmann
  14. Hermann Haller
  15. Florian P Limbourg  Is a corresponding author
  1. Medizinische Hochschule Hannover, Germany
  2. Goethe Universität Frankfurt, Germany
  3. University Medical Center of the Johannes Gutenberg-University Mainz, Germany
  4. Institute of Infection Immunology, Twincore, Germany
  5. Technical University Munich, Germany

Abstract

Conventional Ly6Chi monocytes have developmental plasticity for a spectrum of differentiated phagocytes. Here we show, using conditional deletion strategies in a mouse model of Toll-like receptor (TLR) 7-induced inflammation, that the spectrum of developmental cell fates of Ly6Chi monocytes, and the resultant inflammation, is coordinately regulated by TLR and Notch signaling. Cell-intrinsic Notch2 and TLR7-Myd88 pathways independently and synergistically promote Ly6Clo patrolling monocyte development from Ly6Chi monocytes under inflammatory conditions, while impairment in either signaling axis impairs Ly6Clo monocyte development. At the same time, TLR7 stimulation in the absence of functional Notch2 signaling promotes resident tissue macrophage gene expression signatures in monocytes in the blood and ectopic differentiation of Ly6Chi monocytes into macrophages and dendritic cells, which infiltrate the spleen and major blood vessels and are accompanied by aberrant systemic inflammation. Thus, Notch2 is a master regulator of Ly6Chi monocyte cell fate and inflammation in response to TLR signaling.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.Data from RNA sequencing have been deposited to NCBI's Gene Expression Omnibus and are available under the accession number GSE147492.

The following data sets were generated

Article and author information

Author details

  1. Jaba Gamrekelashvili

    Dept of Nephrology and Hypertension, Medizinische Hochschule Hannover, Hannover, Germany
    For correspondence
    Gamrekelashvli.Jaba@mh-hannover.de
    Competing interests
    The authors declare that no competing interests exist.
  2. Tamar Kapanadze

    Dept of Nephrology and Hypertension, Medizinische Hochschule Hannover, Hannover, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Stefan Sablotny

    Dept of Nephrology and Hypertension, Medizinische Hochschule Hannover, Hannover, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Corina Ratiu

    Institut für Kardiovaskuläre Physiologie, Goethe Universität Frankfurt, Frankfurt, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Khaled Dastagir

    Dept of Nephrology and Hypertension, Medizinische Hochschule Hannover, Hannover, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Matthias Lochner

    Institute of Medical Microbiology and Hospital Epidemiology, Medizinische Hochschule Hannover, Hannover, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Susanne Karbach

    Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Philip Wenzel

    Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Andre Sitnow

    Dept of Nephrology and Hypertension, Medizinische Hochschule Hannover, Hannover, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Susanne Fleig

    Dept of Nephrology and Hypertension, Medizinische Hochschule Hannover, Hannover, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Tim Sparwasser

    Centre for Experimental and Clinical Infection Research, Institute of Infection Immunology, Twincore, Hannover, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Ulrich Kalinke

    Cluster of Excellence-Resolving Infection Susceptibility (RESIST),, Medizinische Hochschule Hannover, Hannover, Germany
    Competing interests
    The authors declare that no competing interests exist.
  13. Bernhard Holzmann

    Department of Surgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  14. Hermann Haller

    Dept of Nephrology and Hypertension, Medizinische Hochschule Hannover, Hannover, Germany
    Competing interests
    The authors declare that no competing interests exist.
  15. Florian P Limbourg

    Dept of Nephrology and Hypertension, Medizinische Hochschule Hannover, Hannover, Germany
    For correspondence
    limbourg.florian@mh-hannover.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8313-7226

Funding

Deutsche Forschungsgemeinschaft (GA 2443/2-1)

  • Jaba Gamrekelashvili

Deutsche Forschungsgemeinschaft (Li948-7/1)

  • Florian P Limbourg

Deutsche Stiftung für Herzforschung (F/17/16)

  • Jaba Gamrekelashvili

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were performed with 8-12 weeks old mice and age and sex matched littermate controls with approval of the local animal welfare board LAVES (Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit), Lower Saxony, Animal Studies Committee, animal study proposals #14-1666, #16-2251, #18-2777, #2014-63, #2018-221). Mice were housed in the central animal facility of Hannover Medical School (ZTL) and were maintained and supervised as approved by the Institutional Animal Welfare Officer (Tierschutzbeauftragter).

Copyright

© 2020, Gamrekelashvili et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,519
    views
  • 447
    downloads
  • 58
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jaba Gamrekelashvili
  2. Tamar Kapanadze
  3. Stefan Sablotny
  4. Corina Ratiu
  5. Khaled Dastagir
  6. Matthias Lochner
  7. Susanne Karbach
  8. Philip Wenzel
  9. Andre Sitnow
  10. Susanne Fleig
  11. Tim Sparwasser
  12. Ulrich Kalinke
  13. Bernhard Holzmann
  14. Hermann Haller
  15. Florian P Limbourg
(2020)
Notch and TLR signaling coordinate monocyte cell fate and inflammation
eLife 9:e57007.
https://doi.org/10.7554/eLife.57007

Share this article

https://doi.org/10.7554/eLife.57007

Further reading

    1. Immunology and Inflammation
    Josep Garnica, Patricia Sole ... Pere Santamaria
    Research Article

    Chronic antigenic stimulation can trigger the formation of interleukin 10 (IL-10)-producing T-regulatory type 1 (TR1) cells in vivo. We have recently shown that murine T-follicular helper (TFH) cells are precursors of TR1 cells and that the TFH-to-TR1 cell transdifferentiation process is characterized by the progressive loss and acquisition of opposing transcription factor gene expression programs that evolve through at least one transitional cell stage. Here, we use a broad range of bulk and single-cell transcriptional and epigenetic tools to investigate the epigenetic underpinnings of this process. At the single-cell level, the TFH-to-TR1 cell transition is accompanied by both, downregulation of TFH cell-specific gene expression due to loss of chromatin accessibility, and upregulation of TR1 cell-specific genes linked to chromatin regions that remain accessible throughout the transdifferentiation process, with minimal generation of new open chromatin regions. By interrogating the epigenetic status of accessible TR1 genes on purified TFH and conventional T-cells, we find that most of these genes, including Il10, are already poised for expression at the TFH cell stage. Whereas these genes are closed and hypermethylated in Tconv cells, they are accessible, hypomethylated, and enriched for H3K27ac-marked and hypomethylated active enhancers in TFH cells. These enhancers are enriched for binding sites for the TFH and TR1-associated transcription factors TOX-2, IRF4, and c-MAF. Together, these data suggest that the TR1 gene expression program is genetically imprinted at the TFH cell stage.

    1. Genetics and Genomics
    2. Immunology and Inflammation
    Stephanie Guillet, Tomi Lazarov ... Frédéric Geissmann
    Research Article

    Systemic lupus erythematosus (SLE) is an autoimmune disease, the pathophysiology and genetic basis of which are incompletely understood. Using a forward genetic screen in multiplex families with SLE, we identified an association between SLE and compound heterozygous deleterious variants in the non-receptor tyrosine kinases (NRTKs) ACK1 and BRK. Experimental blockade of ACK1 or BRK increased circulating autoantibodies in vivo in mice and exacerbated glomerular IgG deposits in an SLE mouse model. Mechanistically, NRTKs regulate activation, migration, and proliferation of immune cells. We found that the patients’ ACK1 and BRK variants impair efferocytosis, the MERTK-mediated anti-inflammatory response to apoptotic cells, in human induced pluripotent stem cell (hiPSC)-derived macrophages, which may contribute to SLE pathogenesis. Overall, our data suggest that ACK1 and BRK deficiencies are associated with human SLE and impair efferocytosis in macrophages.